Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
$0.00
$0.00
$1.10
$37.90
$1K1.9811,850 shs895,787 shs
IAGX
Imagenetix
$0.00
$0.00
$0.00
$0.00
N/A1.33N/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
$0.00
$0.00
$0.15
N/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
$0.00
$0.00
$0.05
$4K1.94N/AN/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
-28.75%-24.00%-52.50%-71.21%-92.45%
IAGX
Imagenetix
0.00%0.00%0.00%0.00%-93.33%
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
0.00%0.00%0.00%0.00%-96.00%
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
IAGX
Imagenetix
N/AN/AN/AN/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
N/AN/AN/AN/A
IAGX
Imagenetix
N/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
$170K0.01N/AN/A($0.59) per share0.00
IAGX
Imagenetix
N/AN/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
$25.80M0.00N/AN/AN/ANaN
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
-$400KN/A0.00N/A-6,075.54%N/A-279.35%N/A
IAGX
Imagenetix
N/AN/A0.00N/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
-$1.07MN/A0.00N/AN/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
N/AN/AN/AN/AN/A
IAGX
Imagenetix
N/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
N/A
IAGX
Imagenetix
N/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/A

Insider Ownership

CompanyInsider Ownership
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
5.61%
IAGX
Imagenetix
N/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
4.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Endonovo Therapeutics, Inc. stock logo
ENDVD
Endonovo Therapeutics
147,0001.23 millionN/ANot Optionable
IAGX
Imagenetix
528.57 millionN/ANot Optionable
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
7882.95 millionN/ANot Optionable
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
2,01835.55 millionN/ANot Optionable

IAGX, PARNF, SPHS, and ENDVD Headlines

Media Sentiment Over Time

Company Descriptions

Endonovo Therapeutics logo

Endonovo Therapeutics

OTCMKTS:ENDVD
Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development of bio-electronic approach to regenerative medicine. The firm also develops, manufactures and distributes evolutionary medical devices focused on the healing of wounds and reduction of pain, edema and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, SofPulse, Electroceutical Therapy, and Scientific Studies. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.

Imagenetix

OTCMKTS:IAGX
Imagenetix, Inc. develops, formulates, and markets proprietary and natural based nutritional supplements, and over-the-counter topical creams and skin care products. Its primary product is Celadrin, a product formulation for joint health. The company also licenses its intellectual property to third parties. Imagenetix, Inc. markets its products through various channels of distribution, including direct and mass marketing companies, nutritional newsletters, and medical and nutritional oriented professionals; medical newsletters; and direct response radio and television. The company was founded in 1996 and is based in San Diego, California.
Parnell Pharmaceuticals logo

Parnell Pharmaceuticals

OTCMKTS:PARNF
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.
Sophiris Bio logo

Sophiris Bio

OTCMKTS:SPHS
Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.